Michelle Gaylord
University of California, Santa Barbara
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michelle Gaylord.
Chemistry & Biology | 2009
Yama A. Abassi; Biao Xi; Wenfu Zhang; Peifang Ye; Shelli L. Kirstein; Michelle Gaylord; Stuart C. Feinstein; Xiaobo Wang; Xiao Xu
We describe a cell-based kinetic profiling approach using impedance readout for monitoring the effect of small molecule compounds. This noninvasive readout allows continuous sampling of cellular responses to biologically active compounds and the ensuing kinetic profile provides information regarding the temporal interaction of compounds with cells. The utility of this approach was tested by screening a library containing FDA approved drugs, experimental compounds, and nature compounds. Compounds with similar activity produced similar impedance-based time-dependent cell response profiles (TCRPs). The compounds were clustered based on TCRP similarity. We identified novel mechanisms for existing drugs, confirmed previously reported calcium modulating activity for COX-2 inhibitor celecoxib, and identified an additional mechanism for the experimental compound monastrol. We also identified and characterized a new antimitotic agent. Our findings indicate that the TCRP approach provides predictive mechanistic information for small molecule compounds.
Biophysical Journal | 2009
Myung Chul Choi; Uri Raviv; Herb P. Miller; Michelle Gaylord; E. Kiris; D. Ventimiglia; Daniel J. Needleman; Mahn Won Kim; Les Wilson; Stuart C. Feinstein; Cyrus R. Safinya
Microtubules (MTs), a major component of the eukaryotic cytoskeleton, are 25 nm protein nanotubes with walls comprised of assembled protofilaments built from alphabeta heterodimeric tubulin. In neural cells, different isoforms of the microtubule-associated-protein (MAP) tau regulate tubulin assembly and MT stability. Using synchrotron small angle x-ray scattering (SAXS), we have examined the effects of all six naturally occurring central nervous system tau isoforms on the assembly structure of taxol-stabilized MTs. Most notably, we found that tau regulates the distribution of protofilament numbers in MTs as reflected in the observed increase in the average radius R(MT) of MTs with increasing Phi, the tau/tubulin-dimer molar ratio. Within experimental scatter, the change in R(MT) seems to be isoform independent. Significantly, R(MT) was observed to rapidly increase for 0 < Phi < 0.2 and saturate for Phi between 0.2-0.5. Thus, a local shape distortion of the tubulin dimer on tau binding, at coverages much less than a monolayer, is spread collectively over many dimers on the scale of protofilaments. This implies that tau regulates the shape of protofilaments and thus the spontaneous curvature C(o)(MT) of MTs leading to changes in the curvature C(MT) (=1/R(MT)). An important biological implication of these findings is a possible allosteric role for tau where the tau-induced shape changes of the MT surface may effect the MT binding activity of other MAPs present in neurons. Furthermore, the results, which provide insight into the regulation of the elastic properties of MTs by tau, may also impact biomaterials applications requiring radial size-controlled nanotubes.
Journal of Biological Chemistry | 2008
Adria C. LeBoeuf; Sasha F. Levy; Michelle Gaylord; Arnab Bhattacharya; Ambuj K. Singh; Mary Ann Jordan; Leslie Wilson; Stuart C. Feinstein
Mutations affecting either the structure or regulation of the microtubule-associated protein Tau cause neuronal cell death and dementia. However, the molecular mechanisms mediating these deleterious effects remain unclear. Among the most characterized activities of Tau is the ability to regulate microtubule dynamics, known to be essential for proper cell function and viability. Here we have tested the hypothesis that Tau mutations causing neurodegeneration also alter the ability of Tau to regulate the dynamic instability behaviors of microtubules. Using in vitro microtubule dynamics assays to assess average microtubule growth rates, microtubule growth rate distributions, and catastrophe frequencies, we found that all tested mutants possessing amino acid substitutions or deletions mapping to either the repeat or interrepeat regions of Tau do indeed compromise its ability to regulate microtubule dynamics. Further mutational analyses suggest a novel mechanism of Tau regulatory action based on an “alternative core” of microtubule binding and regulatory activities composed of two repeats and the interrepeat between them. In this model, the interrepeat serves as the primary regulator of microtubule dynamics, whereas the flanking repeats serve as tethers to properly position the interrepeat on the microtubule. Importantly, since there are multiple interrepeats on each Tau molecule, there are also multiple cores on each Tau molecule, each with distinct mechanistic capabilities, thereby providing significant regulatory potential. Taken together, the data are consistent with a microtubule misregulation mechanism for Tau-mediated neuronal cell death and provide a novel mechanistic model for normal and pathological Tau action.
Journal of Biological Chemistry | 2011
Erkan Kiris; Donovan Ventimiglia; Mehmet Emre Sargin; Michelle Gaylord; Alphan Altinok; Kenneth Rose; B. S. Manjunath; Mary Ann Jordan; Leslie Wilson; Stuart C. Feinstein
Tau is a multiply phosphorylated protein that is essential for the development and maintenance of the nervous system. Errors in Tau action are associated with Alzheimer disease and related dementias. A huge literature has led to the widely held notion that aberrant Tau hyperphosphorylation is central to these disorders. Unfortunately, our mechanistic understanding of the functional effects of combinatorial Tau phosphorylation remains minimal. Here, we generated four singly pseudophosphorylated Tau proteins (at Thr231, Ser262, Ser396, and Ser404) and four doubly pseudophosphorylated Tau proteins using the same sites. Each Tau preparation was assayed for its abilities to promote microtubule assembly and to regulate microtubule dynamic instability in vitro. All four singly pseudophosphorylated Tau proteins exhibited loss-of-function effects. In marked contrast to the expectation that doubly pseudophosphorylated Tau would be less functional than either of its corresponding singly pseudophosphorylated forms, all of the doubly pseudophosphorylated Tau proteins possessed enhanced microtubule assembly activity and were more potent at regulating dynamic instability than their compromised singly pseudophosphorylated counterparts. Thus, the effects of multiple pseudophosphorylations were not simply the sum of the effects of the constituent single pseudophosphorylations; rather, they were generally opposite to the effects of singly pseudophosphorylated Tau. Further, despite being pseudophosphorylated at different sites, the four singly pseduophosphorylated Tau proteins often functioned similarly, as did the four doubly pseudophosphorylated proteins. These data lead us to reassess the conventional view of combinatorial phosphorylation in normal and pathological Tau action. They may also be relevant to the issue of combinatorial phosphorylation as a general regulatory mechanism.
Molecular Cancer Therapeutics | 2009
Wanhong Xu; Biao Xi; Jieying Wu; Haoyun An; Jenny Zhu; Yama A. Abassi; Stuart C. Feinstein; Michelle Gaylord; Baoqin Geng; Huifang Yan; Weimin Fan; Meihua Sui; Xiaobo Wang; Xiao Xu
Bis(4-fluorobenzyl)trisulfide (BFBTS) is a synthetic molecule derived from a bioactive natural product, dibenzyltrisulfide, found in a subtropical shrub, Petiveria allieacea. BFBTS has potent anticancer activities to a broad spectrum of tumor cell lines with IC50 values from high nanomolar to low micromolar and showed equal anticancer potency between tumor cell lines overexpressing multidrug-resistant gene, MDR1 (MCF7/adr line and KBv200 line), and their parental MCF7 line and KB lines. BFBTS inhibited microtubule polymerization dynamics in MCF7 cells, at a low nanomolar concentration of 54 nmol/L, while disrupting microtubule filaments in cells at low micromolar concentration of 1 μmol/L. Tumor cells treated with BFBTS were arrested at G2-M phase, conceivably resulting from BFBTS-mediated antimicrotubule activities. Mass spectrometry studies revealed that BFBTS bound and modified β-tubulin at residue Cys12, forming β-tubulin-SS-fluorobenzyl. The binding site differs from known antimicrotubule agents, suggesting that BFBTS functions as a novel antimicrotubule agent. BFBTS at a dose of 25 mg/kg inhibited tumor growth with relative tumor growth rates of 19.91%, 18.5%, and 23.42% in A549 lung cancer, Bcap-37 breast cancer, and SKOV3 ovarian cancer xenografts, respectively. Notably, BFBTS was more potent against MDR1-overexpressing MCF7/adr breast cancer xenografts with a relative tumor growth rate of 12.3% than paclitaxel with a rate of 43.0%. BFBTS displays a novel antimicrotubule agent with potentials for cancer therapeutics. [Mol Cancer Ther 2009;8(12):3318–30]
Journal of Neurochemistry | 2016
H. Eric Feinstein; Sarah J. Benbow; Nichole E. LaPointe; Nirav Patel; Thanh D. Do; Michelle Gaylord; Noelle E. Huskey; Nicolette Dressler; Megan Korff; Brady Quon; Kristi Lazar Cantrell; Michael T. Bowers; Ratnesh Lal; Stuart C. Feinstein
Despite extensive structure‐function analyses, the molecular mechanisms of normal and pathological tau action remain poorly understood. How does the C‐terminal microtubule‐binding region regulate microtubule dynamics and bundling? In what biophysical form does tau transfer trans‐synaptically from one neuron to another, promoting neurodegeneration and dementia? Previous biochemical/biophysical work led to the hypothesis that tau can dimerize via electrostatic interactions between two N‐terminal ‘projection domains’ aligned in an anti‐parallel fashion, generating a multivalent complex capable of interacting with multiple tubulin subunits. We sought to test this dimerization model directly. Native gel analyses of full‐length tau and deletion constructs demonstrate that the N‐terminal region leads to multiple bands, consistent with oligomerization. Ferguson analyses of native gels indicate that an N‐terminal fragment (tau45–230) assembles into heptamers/octamers. Ferguson analyses of denaturing gels demonstrates that tau45–230 can dimerize even in sodium dodecyl sulfate. Atomic force microscopy reveals multiple levels of oligomerization by both full‐length tau and tau45–230. Finally, ion mobility–mass spectrometric analyses of tau106–144, a small peptide containing the core of the hypothesized dimerization region, also demonstrate oligomerization. Thus, multiple independent strategies demonstrate that the N‐terminal region of tau can mediate higher order oligomerization, which may have important implications for both normal and pathological tau action.
BMC Bioinformatics | 2008
Arnab Bhattacharya; Sasha F. Levy; Adria C. LeBoeuf; Michelle Gaylord; Leslie Wilson; Ambuj K. Singh; Stuart C. Feinstein
BackgroundInnumerable biological investigations require comparing collections of molecules, cells or organisms to one another with respect to one or more of their properties. Almost all of these comparisons are performed manually, which can be susceptible to inadvertent bias as well as miss subtle effects. The development and application of computer-assisted analytical and interpretive tools could help address these issues and thereby dramatically improve these investigations.ResultsWe have developed novel computer-assisted analytical and interpretive tools and applied them to recent studies examining the ability of 3-repeat and 4-repeat tau to regulate the dynamic behavior of microtubules in vitro. More specifically, we have developed an automated and objective method to define growth, shortening and attenuation events from real time videos of dynamic microtubules, and demonstrated its validity by comparing it to manually assessed data. Additionally, we have used the same data to develop a general strategy of building different models of interest, computing appropriate dissimilarity functions to compare them, and embedding them on a two-dimensional plot for visualization and easy comparison. Application of these methods to assess microtubule growth rates and growth rate distributions established the validity of the embedding procedure and revealed non-linearity in the relationship between the tau:tubulin molar ratio and growth rate distribution.ConclusionThis work addresses the need of the biological community for rigorously quantitative and generally applicable computational tools for comparative studies. The two-dimensional embedding method retains the inherent structure of the data, and yet markedly simplifies comparison between models and parameters of different samples. Most notably, even in cases where numerous parameters exist by which to compare the different samples, our embedding procedure provides a generally applicable computational strategy to detect subtle relationships between different molecules or conditions that might otherwise escape manual analyses.
Bulletin of the American Physical Society | 2010
Myung Chul Choi; Uri Raviv; Herb P. Miller; Michelle Gaylord; Erkan Kiris; Donovan Ventimiglia; Daniel J. Needleman; P.J. Chung; J. Deek; N. LaPointe; Mincheol Kim; Leslie Wilson; Stuart C. Feinstein; Cyrus R. Safinya
Biophysical Journal | 2010
Myung Chul Choi; Uri Raviv; Herb P. Miller; Michelle Gaylord; E. Kiris; D. Ventimiglia; Daniel J. Needleman; Peter J. Chung; Joanna Deek; N. LaPointe; Mincheol Kim; Les Wilson; Stuart C. Feinstein; Cyrus R. Safinya
Bulletin of the American Physical Society | 2009
Myung Chul Choi; Uri Raviv; Herbert P. Miller; Michelle Gaylord; Erkan Kiris; Donovan Ventimiglia; Daniel J. Needleman; Mahn Won Kim; Leslie Wilson; Stuart C. Feinstein; Cyrus R. Safinya